News

BostonSight Announces Key Findings in Using PROSE for the Treatment of Neurotrophic Keratitis

Overall, results demonstrated a statistically significant improvement in Mackie Stage (mean) and Visual Acuity (mean) after PROSE treatment among eyes with...

BostonSight Explores Drug-Delivery Use of Scleral Lenses

BostonSight manufactures two scleral lenses, the PROSE device and BostonSight SCLERAL lens, that have been used for decades to treat dry...

Current Scleral Lens Solution Shortages and Alternatives

updated July 22, 2026 Recalls For a complete list from the FDA, please read here. AvKare Eye Drops; Read here. Nutrifill...

Eye Drop Recall Notice June 2026

BostonSight Elects Melissa Albonesi to Board of Directors

Needham, Mass. – May 5, 2026 – BostonSight® announced today the appointment of Melissa Albonesi to the Board of Directors. Ms....

BostonSight SCLERAL Expands Fitting Options with New Smaller Diameter Lenses

FOR IMMEDIATE RELEASE New FitKit® brings diameter range to 14.5mm – 19.0mm Needham, Mass. – April 15, 2026 – BostonSight® today...

BostonSight Unveils 5-Year Roadmap to Advance Scleral Lens Technology, Research, and Education

Needham, Mass. – February 17, 2026.  BostonSight® today announced a transformative 5-year strategic roadmap aimed at redefining ocular surface treatment through...

Michelle Thezin Kong, OD, Joins BostonSight as PROSE Provider

Will expand capacity at the BostonSight Needham PROSE Clinic Needham, Mass. –February 3, 2026.  BostonSight® announced today that Michelle Thezin Kong,...

Dr. Karen Carrasquillo Receives GPLI Practitioner of the Year Award

Needham, Mass. –January 20, 2026.  BostonSight® announced that Karen Carrasquillo, OD, PhD, FAAO, FSLS, FBCLA, has received the 2026 Naomi “Jo”...